BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 11207782)

  • 1. Effects of vigabatrin on brain GABA+/CR signals in patients with epilepsy monitored by 1H-NMR-spectroscopy: responder characteristics.
    Mueller SG; Weber OM; Duc CO; Weber B; Meier D; Russ W; Boesiger P; Wieser HG
    Epilepsia; 2001 Jan; 42(1):29-40. PubMed ID: 11207782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of vigabatrin on brain GABA+/Cr signals in focus-distant and focus-near brain regions monitored by 1H-NMR spectroscopy.
    Mueller SG; Weber OM; Duc CO; Meier D; Russ W; Boesiger P; Wieser HG
    Eur J Neurol; 2003 Jan; 10(1):45-52. PubMed ID: 12534992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effects of vigabatrin on brain GABA and homocarnosine in patients with complex partial seizures.
    Petroff OA; Hyder F; Collins T; Mattson RH; Rothman DL
    Epilepsia; 1999 Jul; 40(7):958-64. PubMed ID: 10403220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial observations on effect of vigabatrin on in vivo 1H spectroscopic measurements of gamma-aminobutyric acid, glutamate, and glutamine in human brain.
    Petroff OA; Rothman DL; Behar KL; Mattson RH
    Epilepsia; 1995 May; 36(5):457-64. PubMed ID: 7614922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of pyridoxal 5'-phosphate alone and in combination with vigabatrin on brain GABA measured by 1H-NMR-spectroscopy.
    Mueller SG; Weber OM; Boesiger P; Wieser HG
    Brain Res Bull; 2001 Jul; 55(4):555-60. PubMed ID: 11543957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GABA changes with vigabatrin in the developing human brain.
    Novotny EJ; Hyder F; Shevell M; Rothman DL
    Epilepsia; 1999 Apr; 40(4):462-6. PubMed ID: 10219272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of gabapentin on brain GABA, homocarnosine, and pyrrolidinone in epilepsy patients.
    Petroff OA; Hyder F; Rothman DL; Mattson RH
    Epilepsia; 2000 Jun; 41(6):675-80. PubMed ID: 10840398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topiramate increases brain GABA, homocarnosine, and pyrrolidinone in patients with epilepsy.
    Petroff OA; Hyder F; Mattson RH; Rothman DL
    Neurology; 1999 Feb; 52(3):473-8. PubMed ID: 10025774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vigabatrin: effects on human brain GABA levels by nuclear magnetic resonance spectroscopy.
    Mattson RH; Petroff O; Rothman D; Behar K
    Epilepsia; 1994; 35 Suppl 5():S29-32. PubMed ID: 8039467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vigabatrin increases human brain homocarnosine and improves seizure control.
    Petroff OA; Mattson RH; Behar KL; Hyder F; Rothman DL
    Ann Neurol; 1998 Dec; 44(6):948-52. PubMed ID: 9851440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo.
    Rothman DL; Petroff OA; Behar KL; Mattson RH
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5662-6. PubMed ID: 8516315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of vigabatrin (gamma-vinyl GABA) on cerebral blood flow and metabolism.
    Spanaki MV; Siegel H; Kopylev L; Fazilat S; Dean A; Liow K; Ben-Menachem E; Gaillard WD; Theodore WH
    Neurology; 1999 Oct; 53(7):1518-22. PubMed ID: 10534261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topiramate rapidly raises brain GABA in epilepsy patients.
    Petroff OA; Hyder F; Rothman DL; Mattson RH
    Epilepsia; 2001 Apr; 42(4):543-8. PubMed ID: 11440351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of intracerebral γ-aminobutyric acid (GABA) levels by titration with levetiracetam in patients with focal epilepsies.
    Doelken MT; Hammen T; Bogner W; Mennecke A; Stadlbauer A; Boettcher U; Doerfler A; Stefan H
    Epilepsia; 2010 Aug; 51(8):1477-82. PubMed ID: 20345933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localized 1H NMR measurements of 2-pyrrolidinone in human brain in vivo.
    Hyder F; Petroff OA; Mattson RH; Rothman DL
    Magn Reson Med; 1999 May; 41(5):889-96. PubMed ID: 10332870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human brain gamma-aminobutyric acid levels and seizure control following initiation of vigabatrin therapy.
    Petroff OA; Behar KL; Mattson RH; Rothman DL
    J Neurochem; 1996 Dec; 67(6):2399-404. PubMed ID: 8931472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of vigabatrin on the GABAergic system as determined by [123I]iomazenil SPECT and GABA MRS.
    Verhoeff NP; Petroff OA; Hyder F; Zoghbi SS; Fujita M; Rajeevan N; Rothman DL; Seibyl JP; Mattson RH; Innis RB
    Epilepsia; 1999 Oct; 40(10):1433-8. PubMed ID: 10528940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton MR spectroscopy of metabolite concentrations in temporal lobe epilepsy and effect of temporal lobe resection.
    Simister RJ; McLean MA; Barker GJ; Duncan JS
    Epilepsy Res; 2009 Feb; 83(2-3):168-76. PubMed ID: 19118980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vigabatrin.
    French JA
    Epilepsia; 1999; 40 Suppl 5():S11-6. PubMed ID: 10530689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vigabatrin in the treatment of intractable focal epilepsy in children and adolescents. Two-year study].
    Kozik A; Ujma-Czapska B; Grotowska M
    Neurol Neurochir Pol; 2000; 34 Suppl 1():187-93. PubMed ID: 10768158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.